| Clinical and Radiological Manifestations of Coxitis in Patients With Ankylosing Spondylitis Treated With Golimumab (NCT03557853) | MSD Pharmaceuticals LLC | 2016-06-01 |
| Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial) (NCT02538341) | University of Alabama at Birmingham | 2016-05-01 |
| Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE) (NCT02750800) | AbbVie | 2016-04-07 |
| Study of Efficacy and Safety of Secukinumab in Japanese Patients With Active Ankylosing Spondylitis (NCT02750592) | Novartis Pharmaceuticals | 2016-03-22 |
| Electroacupuncture for Relieving Pain in Ankylosing Spondylitis (NCT02697968) | The University of Hong Kong | 2016-03-01 |
| Stretching in Water and on Land for Patients With Ankylosing Spondylitis (NCT03667625) | Dokuz Eylul University | 2016-02-01 |
| Alexithymia in Ankylosing Spondylitis (NCT04320459) | Istanbul Medeniyet University | 2016-02-01 |
| Comparative Clinical Trial to Evaluate Efficacy and Safety of BCD-055 and Remicade® in Patients With Ankylosing Spondylitis (NCT02762812) | Biocad | 2016-01-01 |
| WEB-Based Physiotherapy for People With Axial Spondyloarthritis (NCT02666313) | Dr Lorna Paul | 2015-11-01 |
| Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Patients Treated by Anti-TNF Therapy in the Prevention of Radiographic Outcomes (NCT02469753) | University Hospital, Bordeaux | 2015-10-23 |
| Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From Remicade (NCT02605642) | Pfizer | 2015-09-10 |
| Epicardial Adipose Tissue Thickness and the Related Factors in Patients With Ankylosing Spondylitis (NCT06094686) | Istanbul Physical Medicine Rehabilitation Training and Research Hospital | 2015-08-01 |
| Phenomics in Autoimmune and Inflammatory Diseases (NCT02466217) | Assistance Publique - Hôpitaux de Paris | 2015-07-29 |
| Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to Placebo (NCT02505542) | UCB BIOSCIENCES GmbH | 2015-07-01 |
| An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With Ankylosing Spondylitis (NCT02557308) | Celltrion | 2015-05-26 |
| Efficacy and Safety of Loxoprofen Hydrogel Patch in Patients With Ankylosing Spondylitis (NCT03800797) | Sun Yat-sen University | 2015-05-25 |
| Biomarkers Identification of Anti-tumor Necrosis Factor (TNF) α Agent's Efficacy in Ankylosing Spondylitis Patients (NCT02492217) | Universidade Nova de Lisboa | 2015-05-01 |
| Comparative Evaluation of Pharmacokinetics and Safety of BCD-055 and Remicade in Patients With Ankylosing Spondylitis (NCT02359903) | Biocad | 2015-02-01 |
| Biomarkers in Early-stage Spondyloarthritis (NCT04095169) | Spine Centre of Southern Denmark | 2015-01-01 |
| Observe the Frequency of Extra-Axial Symptoms in Korean Ankylosing Spondylitis (AS) Patients (NCT02333383) | AbbVie | 2014-12-31 |
| 99mTc-rhAnnexin V-128 a Phase I/IIa Study in Patients With Rheumatoid Arthritis (RA) or Ankylosing Spondylitis (AS) (NCT02328027) | Advanced Accelerator Applications | 2014-12-11 |
| Combined Treatment With TNF Inhibitor and Pamidronate in AS Patients: Effect on the Radiographic Progression (NCT02313727) | Bnai Zion Medical Center | 2014-12-01 |
| Physical Training Program in Ankylosing Spondylitis (NCT02284646) | University Hospital, Toulouse | 2014-11-25 |
| Frequency and Complications of Major Orthopedic Procedures in Medicare Beneficiaries (NCT02281747) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2014-10-24 |
| The Effect of Acupuncture in Treating Chronic Low-back Pain (NCT02260284) | Chengdu PLA General Hospital | 2014-10-01 |
| Etanercept and Celecoxib Alone/Combined Treatment in Effectiveness and Safety of Active Ankylosing Spondylitis (NCT01934933) | Sun Yat-sen University | 2014-09-24 |
| A Study of Golimumab in Participants With Active Ankylosing Spondylitis (NCT02186873) | Janssen Research & Development, LLC | 2014-09-03 |
| Does Immunogenicity Have an Influence on the Efficacy of Anti-TNF Therapy in Patients With AS: An Inception Cohort Study (NCT02687620) | Izmir Katip Celebi University | 2014-09-01 |
| A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers (NCT02154425) | UCB BIOSCIENCES, Inc. | 2014-09-01 |
| Defining Remission With Etanercept in AS in Real Life Clinical Practice (NCT02202850) | Pfizer | 2014-08-12 |
| Assessment of Treatment Safety and Quality of Life in Patients Receiving Etanercept Biosimilar for Autoimmune Arthritis (NCT04582084) | AryoGen Pharmed Co. | 2014-04-04 |
| Safety and Efficacy Study of Prefilled Liquid Etanercept(Yisaipu) for Active Ankylosing Spondylitis (NCT04345458) | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 2014-03-06 |
| Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases (NCT01988506) | Assistance Publique - Hôpitaux de Paris | 2014-01-06 |
| A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta (NCT02019602) | UCB BIOSCIENCES, Inc. | 2014-01-01 |
| Assial - Anti Tnf Treatment in Ankylosing Spondylitis: an Observational Cohort Study in Italy (NCT01856569) | Pfizer | 2013-07-01 |
| At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions (NCT01931644) | Sanguine Biosciences | 2013-07-01 |
| A Study to Assess the Safety and Effectiveness of Golimumab in Filipino Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (NCT01692457) | Janssen Pharmaceutica | 2013-07-01 |
| Study in Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) Patients to Evaluate Work Productivity Before and After the Start of Adalimumab Therapy in Daily Practice in Belgium (NCT01845818) | AbbVie | 2013-06-05 |
| Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (NCT02132234) | Jagiellonian University | 2013-06-01 |
| Employment and Arthritis: Making it Work (NCT01852851) | University of British Columbia | 2013-06-01 |
| Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis (NCT01786668) | Pfizer | 2013-04-01 |
| Effect of the Combination of Methotrexate and Adalimumab on Reduction of Immunization in Ankylosing Spondylitis (COMARIS) (NCT01895764) | University Hospital, Tours | 2013-03-20 |
| Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice (NCT01768858) | AbbVie | 2013-02-05 |
| Phase II Clinical Study of Thalidomide in the Treatment of Ankylosing Spondylitis (NCT02201043) | Shanghai Pharmaceuticals Holding Co., Ltd | 2013-02-01 |
| Functional Limitations Due To The Foot Involvement In Spondyloarthritis (NCT01833468) | Vakif Gureba Training and Research Hospital | 2013-02-01 |
| Effects of Rosuvastatin on Carotid Artery Plaques in Patients With Inflammatory Joint Disease (NCT01389388) | Diakonhjemmet Hospital | 2013-01-01 |
| Impact of Adalimumab (Humira®) Therapy on Selected Health Care Resource Utilization and Sick Leave in Patients With Ankylosing Spondylitis in Clinical Practice (NCT01754727) | AbbVie (prior sponsor, Abbott) | 2012-12-01 |
| Korean College of Rheumatology Biologics and Targeted Therapy Registry (NCT01965132) | Seoul National University Hospital | 2012-12-01 |
| The Incidence of Extra-Articular Manifestations in Participants With Ankylosing Spondylitis Treated With Golimumab (MK-8259-012) (NCT01668004) | Merck Sharp & Dohme LLC | 2012-09-03 |
| Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα (NCT01694264) | Seoul National University Hospital | 2012-09-01 |
| Prevalence and Progression of Periodontitis in Ankylosing Spondylitis (NCT01750528) | Seoul National University Hospital | 2012-09-01 |
| Efficacy and Safety of MEthylprednisolone Administered Intravenously for the Treatment of Patients With Active AnkyLosing spondyLitis (METALL) (NCT01790022) | Saratov State Medical University | 2012-07-01 |
| Exercise Therapy Program in Ankylosing Spondylitis Patients (NCT01690273) | University of Sao Paulo | 2012-07-01 |
| The Usefulness of Interferon-γ Release Assays and Tuberculin Skin Test for Detection of Latent Tuberculosis Infection (NCT01685905) | Hanyang University | 2012-04-01 |
| OTIS Cimzia Pregnancy Registry (NCT01797224) | University of California, San Diego | 2012-03-01 |
| A Molecule Basic Study of Early Warning for New Pathogenic Risk of Ankylosing Spondylitis (NCT01709656) | Sun Yat-sen University | 2012-03-01 |
| Assessment of NSAID-treated Patients Adherence to Co-prescribed Proton Pump Inhibitor (PPI) (NCT01519375) | AstraZeneca | 2012-03-01 |
| An Extension Study to Demonstrate the Equivalence of Long-Term Efficacy and Safety of CT-P13 in Patients With Ankylosing Spondylitis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 1.1 (NCT01571206) | Celltrion | 2012-03-01 |
| To Investigate Genetic Factors Associated With the Response to Anti-TNF Therapy in Patients With Early AS (NCT02311842) | Sun Yat-sen University | 2012-01-01 |
| Incidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive Analysis (NCT02922192) | Biologics & Biosimilars Collective Intelligence Consortium | 2012-01-01 |
| Differences in Bone Cell Activity Between Rheumatoid Arthritis and Ankylosing Spondylitis (NCT01417455) | Instituto de Medicina Molecular João Lobo Antunes | 2012-01-01 |
| Descriptive Study in Patients Treated With Vimovo™, Including Registration of the Physicians' Prescribing Patterns (NCT01511926) | AstraZeneca | 2012-01-01 |
| Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis (NCT01474876) | AbbVie (prior sponsor, Abbott) | 2011-11-01 |
| Total Glucosides Paeony Capsules in Maintaining Clinical Remission in Patients With Ankylosing Spondylitis Which Achieve Clinical Remission After Anti-TNF Therapy (NCT01517620) | Sun Yat-sen University | 2011-11-01 |
| Ustekinumab for the Treatment of Patients With Active Ankylosing Spondylitis (NCT01330901) | Charite University, Berlin, Germany | 2011-10-01 |
| 16 Week Efficacy and 2 Year Long Term Safety and Efficacy of Secukinumab in Patients With Active Ankylosing Spondylitis (NCT01358175) | Novartis Pharmaceuticals | 2011-10-01 |
| Web-based Support to Manage Arthritis Pain (NCT01463189) | Inflexxion, Inc. | 2011-09-01 |
| Genetic Susceptibility to Ankylosing Spondylitis (AS) by Functional Genomics Approach (NCT02525042) | Assistance Publique - Hôpitaux de Paris | 2011-08-01 |
| Effects of Aerobic Training in Patients With Ankylosing Spondylitis (NCT01586650) | Federal University of São Paulo | 2011-07-01 |
| Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis (NCT01387802) | AbbVie (prior sponsor, Abbott) | 2011-06-29 |
| Greek Study on Work Productivity and Sleep in Patients With Rheumatic Diseases Treated With Adalimumab (NCT01282372) | AbbVie (prior sponsor, Abbott) | 2011-03-01 |
| Effect Of Anti TNF Alpha Therapy And Their Adverse Effects In Ankylosing Spondylitis In A North Indian Population (NCT01361542) | All India Institute of Medical Sciences | 2011-02-01 |
| European Ankylosing Spondylitis Infliximab Cohort (EASIC) Follow up Registration Study (NCT01286545) | Rheumazentrum Ruhrgebiet | 2011-02-01 |
| Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Ankylosing Spondylitis (AS) (NCT01420432) | Shandong University | 2011-01-01 |
| Assessment of Pain Management in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients Who Are About to be Treated With Adalimumab (NCT01273519) | AbbVie (prior sponsor, Abbott) | 2011-01-01 |
| A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department (NCT01411215) | Pfizer | 2011-01-01 |
| An Observational, Retrospective, Multicenter, National Study for the Monitoring of Subjects Who Participated in the LoadET Clinical Trial (NCT01793285) | Pfizer | 2010-12-01 |
| Quality of Life in Chronic Arthritis (NCT01357018) | Far Eastern Memorial Hospital | 2010-11-01 |
| Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation) (NCT01329380) | AbbVie | 2010-10-27 |
| Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in AS Patients(PLANETAS) (NCT01220518) | Celltrion | 2010-10-01 |
| Study of the Safety and Efficacy of Golimumab in Chinese Patients With Ankylosing Spondylitis (NCT01248793) | Centocor, Inc. | 2010-10-01 |
| Assessment of the Response to Etoricoxib in Patients With Ankylosing Spondylitis and Inadequate Response to ≥2 NSAIDs (NCT01091675) | Spanish Foundation of Rheumatology | 2010-09-01 |
| Observational Study on Non-steroid Anti-inflammatory Drugs (NSAIDs) Treated Patients With Arthritic Disorder (NCT01176682) | AstraZeneca | 2010-08-01 |
| Extension Study for Long Term Evaluation of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis (NCT01118728) | Sanofi | 2010-06-01 |
| Effectiveness and Safety of Early Treatment With Infliximab for Hip Arthritis Associated With Ankylosing Spondylitis (AS) (P06451) (NCT01148901) | Merck Sharp & Dohme LLC | 2010-06-01 |
| T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF Blockade (NCT01060098) | Imperial College London | 2010-04-01 |
| Safety and Tolerability of AIN457 in Adults (18-65 Years) With Moderate to Severe Ankylosing Spondylitis (NCT01109940) | Novartis Pharmaceuticals | 2010-04-01 |
| Dose Ranging Study to Evaluate the Efficacy and Safety of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis (NCT01061723) | Sanofi | 2010-02-01 |
| Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylosing Spondylitis (NCT01114880) | Abbott | 2010-01-01 |
| Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis (NCT02456363) | Chung Shan Medical University | 2009-11-01 |
| Work Productivity in Active Ankylosing Spondylitis (AS) Patients Treated With Enbrel. (NCT01421303) | Pfizer | 2009-10-01 |
| Treatment With Alendronate in Patients With Ankylosing Spondylitis (AS) (NCT01104987) | Göteborg University | 2009-10-01 |
| Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1) (NCT00844805) | Merck Sharp & Dohme LLC | 2009-09-01 |
| Spondylitis Trial of Apremilast for Better Rheumatic Therapy (NCT00944658) | Imperial College London | 2009-08-01 |
| Study Of Celecoxib Or Diclofenac For Efficacy and Safety In Chinese Patients With Ankylosing Spondylitis (NCT00762463) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2009-07-01 |
| Golimumab Safety and Surveillance Program Using the Ingenix NHI Database (NCT01081717) | Janssen Biotech, Inc. | 2009-04-14 |
| Study Evaluating Predictors of Response in Patients With Ankylosing Spondylitis (NCT00900796) | Pfizer | 2009-03-01 |
| Clinical Trial of Osteoporosis in Ankylosing Spondylitis (NCT00858819) | Göteborg University | 2009-03-01 |
| A Study of ARRY-371797 in Patients With Active Ankylosing Spondylitis (NCT00811499) | Pfizer | 2008-12-16 |
| Study Evaluating Epidemiology of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in Australia (NCT00751387) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-11-01 |